AAV-mediated gene therapy shows efficacy on the biochemical and neurological phenotype of the nucleoside-enhanced mouse model of MNGIE

被引：0
|
作者：
Vila-Julia, F. [1 ,2 ]
Cabrera-Perez, R. [1 ,2 ]
Lope-Piedrafita, S. [3 ,4 ]
Camara, Y. [1 ,2 ]
Hirano, M. [5 ]
Mingozzi, F. [6 ,7 ,8 ]
Torres-Torronteras, J. [1 ,2 ]
Marti, R. [1 ,2 ]
机构：
[1] Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona, Catalonia, Spain
[2] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis, Madrid, Spain
[3] Univ Autonoma Barcelona, Nucl Magnet Resonance Serv, Cerdanyola Del Valles, Catalonia, Spain
[4] Univ Autonoma Barcelona, Biomed Network Res Ctr Bioengn Biomat & Nanomed, Cerdanyola Del Valles, Catalonia, Spain
[5] Columbia Univ, Dept Neurol, Med Ctr, H Houston Merritt Neuromuscular Res Ctr, New York, NY USA
[6] Genethon, Evry, France
[7] INSERM, U951, Evry, France
[8] Univ Pierre & Marie Curie, Paris, France
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P442
引用
收藏
页码：A147 / A148
页数：2
相关论文
共 50 条
  • [21] AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy study
    Fremuth, Leigh E.
    Hu, Huimin
    van de Vlekkert, Diantha
    Weesner, Jason A.
    Gomero, Elida M.
    d'Azzo, Alessandra
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 44 - 44
  • [22] AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy study
    Hu, Huimin
    Mosca, Rosario
    Gomero, Elida
    van de Vlekkert, Diantha
    Campos, Yvan
    Fremuth, Leigh E.
    Brown, Scott A.
    Weesner, Jason A.
    Annunziata, Ida
    d'Azzo, Alessandra
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 644 - 658
  • [23] Safety and Efficacy of AAV-mediated Gene Replacement Therapy in Bietti Crystalline Corneoretinal Dystrophy
    Yang, Liping
    Wang, Jinyuan
    Zhang, Jinlu
    Yu, Shicheng
    Li, Hongyan
    Chen, Shaohong
    Zhang, Fan
    Qiao, Jing
    Qu, Baoyuan
    Li, Wang
    Wang, Haibo
    Guan, Yuxia
    Zhang, Haihan
    Zhao, Xiuli
    Wang, Likun
    Wei, Wen-bin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [24] Stress-Induced Cardiac Mouse Model of Friedreich's Ataxia Corrected by AAV-Mediated Gene Therapy
    Salami, Christiana O.
    Rosenberg, Jonathan B.
    Jackson, Katie L.
    Alyass, Laith
    Jose, Clarisse L.
    De, Bishnu P.
    Sondhi, Dolan
    Kaminsky, Stephen M.
    Crystal, Ronald G.
    MOLECULAR THERAPY, 2018, 26 (05) : 348 - 348
  • [25] Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease
    Heller, Gregory J.
    Marshall, Michael S.
    Issa, Yazan
    Marshall, Jeffrey N.
    Nguyen, Duc
    Rue, Emily
    Pathmasiri, Koralege C.
    Domowicz, Miriam S.
    van Breemen, Richard B.
    Tai, Leon M.
    Cologna, Stephanie M.
    Crocker, Stephen J.
    Givogri, Maria, I
    Sands, Mark S.
    Bongarzone, Ernesto R.
    MOLECULAR THERAPY, 2021, 29 (05) : 1883 - 1902
  • [26] AAV-MEDIATED GENE THERAPY PRODUCES FERTILE OFFSPRING IN THE LHCGR-DEFICIENT MOUSE MODEL OF LEYDIG CELL FAILURE
    Xia, K.
    Wang, F.
    Lai, X.
    Luo, P.
    Chen, H.
    Ma, Y.
    Huang, W.
    Ou, W.
    Li, Y.
    Feng, X.
    Lei, Z.
    Tu, X.
    Ke, Q.
    Mao, F.
    Deng, C.
    Xiang, A. P.
    CYTOTHERAPY, 2022, 24 (05) : S42 - S42
  • [27] AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD
    Giesige, Carlee R.
    Wallace, Lindsay M.
    Heller, Kristin N.
    Eidahl, Jocelyn O.
    Saad, Nizar Y.
    Fowler, Allison M.
    Pyne, Nettie K.
    Al-Kharsan, Mustafa
    Rashnonejad, Afrooz
    Chermahini, Gholamhossein Amini
    Domire, Jacqueline S.
    Mukweyi, Diana
    Garwick-Coppens, Sara E.
    Guckes, Susan M.
    McLaughlin, K. John
    Meyer, Kathrin
    Rodino-Klapac, Louise R.
    Harper, Scott Q.
    JCI INSIGHT, 2018, 3 (22):
  • [28] AAV-mediated liver directed gene therapy corrects the cholestatic phenotype in Abcb4-/- mice
    Aronson, S. J.
    Bakker, R. S.
    Shi, X.
    Duijst, S.
    ten Bloemendaal, L.
    Beuers, U.
    Paulusma, C. C.
    Bosma, P. J.
    HUMAN GENE THERAPY, 2018, 29 (12) : A132 - A133
  • [29] Gene Therapy Using a Liver-targeted AAV Vector Restores Nucleoside and Nucleotide Homeostasis in a Murine Model of MNGIE
    Torres-Torronteras, Javier
    Viscomi, Carlo
    Cabrera-Perez, Raquel
    Camara, Yolanda
    Di Meo, Ivan
    Barquinero, Jordi
    Auricchio, Alberto
    Pizzorno, Giuseppe
    Hirano, Michio
    Zeviani, Massimo
    Marti, Ramon
    MOLECULAR THERAPY, 2014, 22 (05) : 901 - 907
  • [30] Stress-Induced Mouse Model of the Cardiac Manifestations of Friedreich's Ataxia Corrected by AAV-mediated Gene Therapy
    Salami, Christiana O.
    Jackson, Katie
    Jose, Clarisse
    Alyass, Laith
    Cisse, Georges-Ibrahim
    De, Bishnu P.
    Stiles, Katie M.
    Chiuchiolo, Maria J.
    Sondhi, Dolan
    Crystal, Ronald G.
    Kaminsky, Stephen M.
    HUMAN GENE THERAPY, 2020, 31 (15-16) : 819 - 827
12345